Certara Introduces Certara.AI, the Life Sciences Specialized GPT Platform
Certara.AI Improves Drug Research & Development Processes with Secure, Client-Specific, A.I. Applications PRINCETON, N. J.—October…
CertaraOctober 5, 2023
Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model
Hugo Geerts, Silke Bergeler, Mike Walker, Piet van der Graaf, Jean-Philippe Courade. Sci Rep. 2023…
CertaraOctober 5, 2023
How Modeling Can Help to Improve Children’s Access to Properly Evaluated Medications
Regulatory guidance paves the way to address ethical concerns in pediatric trials, and how additional…
CertaraOctober 5, 2023
Clinical Pharmacology Issues That Can Lead to Approvability Problems for Your Drug
Clinical pharmacology information comprises more than 50% of a drug label. Inadequate clinical pharmacology development…
CertaraOctober 4, 2023
Certara Launches CoAuthor, a Regulatory and Medical Writing Tool
Using AI to gain efficiencies for medical writers PRINCETON, N. J.— October 3, 2023— Certara,…
CertaraOctober 3, 2023
Accelerating a drug launch with value communication technology and an integrated workflow
With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical…
CertaraOctober 2, 2023
Medical Device | Medtronic Demonstrating the economic value of minimally invasive spinal surgery on the iPad
This case study describes the use of a web-based platform to demonstrate the value of…
CertaraOctober 2, 2023
Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)
Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…
CertaraOctober 2, 2023
Unlocking ROI through Omnichannel Stakeholder Engagement and Value Communication in Pharma
In a sector where both competition and stakeholder expectations are high, a comprehensive approach that…
CertaraOctober 2, 2023
